Proteasomal degradation of Mcl-1 by maritoclax induces apoptosis and enhances the efficacy of ABT-737 in melanoma cells.
Metastatic melanoma remains one of the most invasive and highly drug resistant cancers. The over expression of anti-apoptotic protein Mcl-1 has been associated with inferior survival, poor prognosis and chemoresistance of malignant melanoma. A BH3 mimetic, ABT-737, has demonstrated efficacy in sever...
Main Authors: | Manoj K Pandey, Krishne Gowda, Kenichiro Doi, Arun K Sharma, Hong-Gang Wang, Shantu Amin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3817219?pdf=render |
Similar Items
-
RNA silencing of Mcl-1 enhances ABT-737-mediated apoptosis in melanoma: role for a caspase-8-dependent pathway.
by: Angela M Keuling, et al.
Published: (2009-01-01) -
ABT-737 synergizes with Bortezomib to kill melanoma cells
by: Steven N. Reuland, et al.
Published: (2012-02-01) -
Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma.
by: Karianne Risberg, et al.
Published: (2011-01-01) -
Potentiation Of The Nasopharyngeal Carcinoma Cell Lines By Maritoclax To Abt-263 In 2-Dimensional And 3-Dimensional Cell Culture Methods
by: Lian, Benedict Shi Xiang
Published: (2017) -
Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner
by: Irina Kiprianova, et al.
Published: (2015-07-01)